Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years

Journal of the American College of Cardiology

Volumn 39, Issue 1, 2002, Pages 130-137

  Jaeggi, Edgar T ^a,b   Hamilton, Robert M ^a   Silverman, Earl D ^a   Zamora, Samuel A ^b   Hornberger, Lisa K ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY RO; LA ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CANADA; DELIVERY; ENDOCARDIAL FIBROELASTOSIS; FEMALE; FETUS; FETUS HYDROPS; FETUS MORTALITY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NEWBORN; NEWBORN MORTALITY; OUTCOMES RESEARCH; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

AGE FACTORS; CHILD; FEMALE; FETAL DISEASES; HEART BLOCK; HUMANS; HYDROPS FETALIS; MALE; PACEMAKER, ARTIFICIAL; PRENATAL DIAGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0037005784     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01697-7     Document Type: Article

References (36)

1. Congenital complete heart block: An international study of the natural history story
2. Sur une maladie infantile characterisée par des modifications permanente du pouls des attaques syncopales et épileptiformes et la mort subite
3. Association of maternal lupus erythematosus with congenital complete heart block
4. Importance of the immune response to the Ro/La particle in the development of congenital heart block neonatal lupus erythematosus
5. Relationship between maternal neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro) in pregnancies complicated by congenital heart block
6. Maternal antibodies against fetal cardiac antigens in congenital complete heart block
7. New findings in neonatal lupus syndrome
8. Anatomy of congenital complete heart block relation to maternal anti-Ro antibodies
9. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from the national lupus registry
10. Isolated congenital complete heart block: Long term outcome in children and immunogenetic study
11. Clinical serological identification of 2 forms of complete heart block in children
12. Congenital heart block: Review report of the second case of complete heart block studied by serial sections through the conduction system
13. Limiting dilution analysis of Epstein-Barr virus infectable B-cells secreting anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus erythematosus
14. An analysis of the time-relations of electrocardiograms
15. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American college of cardiology/American heart association task force on practice guidelines (committee on pacemaker implantation)
16. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoimmune associated congenital heart block: Retrospective review of the research registry for neonatal lupus
17. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus experience in a mother with predominance of SSB(La) antibodies
18. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus
19. Fetal ventricular pacing for hydrops secondary to complete atrioventricular pacing
20. Successful management of congenital atrioventricular block associated with hydrops fetalis
21. Outcome of isolated complete heart block diagnosed in utero
22. Congenital acute lupus erythematosus associated with subendocardial fibroelastosis: Report of a case
23. Congenital heart block and widespread fibrosis due to maternal lupus erythematosus
24. Maternal connective tissue disease congenital heart block: Demonstration of immunoglobulin in cardiac tissue
25. Primary endocardiofibroelastosis associated with maternal anti-Ro and anti-La antibodies
26. Perinatal outcome of fetal complete atrioventricular block: A multicenter experience
27. Congenital complete heart block: An international study of the natural history
28. Clinical significance of maternal ant-Ro/SS-A antibodies in children with isolated heart block
29. Ro/SS-A and La/SS-B antibody level variation in patients with Sjogren's syndrome and systemic lupus erythematosus
30. Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production
31. Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block
32. Diagnosis management long-term results of patients with complete congenital atrioventricular block
33. Long-term outcome of mothers of children with complete congenital heart block
34. Autoantibody-associated congenital heart block: Outcome in mothers and children
35. Isolated congenital complete atrioventricular block in adult life
36. Congenital heart block in patients without anatomic cardiac defects